Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
204.89
USD
+1.07 (+0.52%)
Official Closing Price
Updated: 7:56 PM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine
February 26, 2021
The number of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 113 million on Friday, amid a flurry of positive vaccine news and as a regulatory advisory committee gathered to...
Tags
JNJ
LLY
SPX
From
MarketWatch
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Earnings
MYGN
LHDX
From
Benzinga
US Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy
February 26, 2021
The U.S. government hasagreed to purchase a minimumof 100,000 doses ofEli Lilly and Co's(NYSE:LLY) ...
Tags
Market News
Benzinga
Biotech
From
Benzinga
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
February 26, 2021
The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals.
From
Investor's Business Daily
Are These Top Health Care Stocks Worth Watching Ahead Of March?
February 25, 2021
Tags
Market News
From
Stockmarket.com
RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today
February 24, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Shares of little-known biopharma firm Relief Therapeutics gained on...
Tags
RLFTF
CDMO
LLY
From
InvestorPlace
Stocks Generating Improved Relative Strength: Eli Lilly
February 24, 2021
Eli Lilly shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
Veru Files US Application For TADFIN Combo For Prostate Enlargement
February 23, 2021
Veru Inc(NASDAQ:VERU) hassubmitted a 505(b)(2) New Drug Applicationwith the FDA for TADFIN (tadalafil 5mg and ...
Tags
Benzinga
News
MRK
From
Benzinga
Should You Follow Cathie Wood Into This Coronavirus Stock?
February 23, 2021
This latest pick has been sluggish so far -- but the long-term opportunity may be huge.
Tags
ARKF
Market News
ARKG
From
Motley Fool
3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
February 21, 2021
Here's why this stock's big run-up in recent months could be just the beginning.
Tags
LLY
Market News
RIGL
From
Motley Fool
Precision Bio's ARCUS Gene Editing Platform Is Safe, Durable; Long-Term Animal Study Shows
February 19, 2021
Precision BioSciences Inc(NASDAQ:DTIL) has announcedthree-year follow-up datashowing long-term stable ...
Tags
DTIL
Benzinga
Small Cap
From
Benzinga
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
February 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
IMCR
PFE
Benzinga
From
Benzinga
RIGL Stock: Why Rigel Pharmaceuticals Is Climbing Today
February 18, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>A newly announced deal between Rigel Pharmaceuticals and sector behemoth...
Tags
Today's Market
RIGL
Market News
From
InvestorPlace
Why Rigel Pharmaceuticals Stock Is Jumping Today
February 18, 2021
The company is teaming up with Eli Lilly on the development of a promising immune disease drug.
Tags
RIGL
Market News
LLY
From
Motley Fool
Lilly Strikes Licensing Deal With Rigel In Push Toward Neurological, Immunological Therapies
February 18, 2021
Eli Lilly And Co (NYSE: LLY) announced a licensing deal Thursday with smaller biopharma Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) that ...
Tags
Trading Ideas
LLY
DNLI
From
Benzinga
Return On Capital Employed Overview: Eli Lilly
February 18, 2021
Looking at Q4, Eli Lilly (NYSE:LLY) earned $1.99 billion, a 55.84% increase from the preceding quarter. Eli Lilly also posted a total of ...
Tags
News
Market News
Earnings
From
Benzinga
Penny Stocks To Buy With Analysts Targeting 76%-209% Upside
February 18, 2021
Tags
Market News
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
February 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SWAV
Offerings
Biotech
From
Benzinga
Dow futures retreat ahead of weekly jobless claims report
February 18, 2021
Futures contracts on U.S. stock-market indexes head modestly lower Thursday morning as investors watch for the latest weekly update on the state of the U.S. labor market amid the COVID pandemic.
Tags
AMC
DJIA
GME
From
MarketWatch
Eli Lilly's Tirzepatide Reduces A1C And Body Weight, Late-Stage Studies In Type 2 Diabetes Show
February 17, 2021
Eli Lilly And Co(NYSE:LLY) haveannounced topline resultsfrom two Phase 3 ...
Tags
Benzinga
Diabetes
Phase 3 Study
From
Benzinga
Noteworthy ETF Outflows: USMV, NEE, LLY, ACN
February 16, 2021
Symbols mentioned in this story: USMV, NEE, LLY, ACN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Large Cap Biopharma Stalled With Move to Small Caps and Reflation Trade
February 15, 2021
Defensive large-cap biopharma stocks stalled as traders moved out on the risk curve seeking faster gains.
Tags
Stocks / Equities
ETFs
Healthcare
From
Blogs - TalkMarkets
Week In Review: Suzhou's Adagene Raises $140 Million In US IPO To Develop Oncology Drugs
February 13, 2021
Adagene, a Suzhou immunoncology biopharma, completed a $140 million NASDAQ IPO and climbed 56% higher in open market trading. Adagene has a market capitalization of about $1 billion.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
3 Stocks to Buy and Hold for the Next Decade: Eli Lilly, HCA Healthcare, and Seagen
February 13, 2021
If there is one lesson the COVID-19 pandemic has taught humanity, it is to value our health over all else.
Tags
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Week in Review: Suzhou's Adagen Raises $140 Million in US IPO to Develop Oncology Drugs
February 13, 2021
Deals and Financings Adagene, a Suzhou immunoncology biopharma, completed a $140 million NASDAQ IPO and climbed 56% higher to a $1 billion valuation; Shanghai Nuance Pharma in-licensed Greater China...
From
ChinaBio® Today
Week in Review: Suzhou's Adagen Raises $140 Million in US IPO to Develop Oncology Drugs
February 13, 2021
Deals and Financings Adagene, a Suzhou immunoncology biopharma, completed a $140 million NASDAQ IPO and climbed 56% higher to a $1 billion valuation; Shanghai Nuance Pharma in-licensed Greater China...
From
ChinaBio® Today
Week in Review: Suzhou's Adagene Raises $140 Million in US IPO to Develop Oncology Drugs
February 13, 2021
Deals and Financings Adagene, a Suzhou immunoncology biopharma, completed a $140 million NASDAQ IPO and climbed 56% higher to a $1 billion valuation; Shanghai Nuance Pharma in-licensed Greater China...
From
ChinaBio® Today
Can Coronavirus Antibodies Overcome Their Obstacles?
February 12, 2021
Issues with timing, delivery, and manufacturing make the treatments less promising.
Tags
LLY
VIR
REGN
From
Motley Fool
Should Investors Be Watching These Top Coronavirus Stocks Right Now?
February 11, 2021
Tags
Market News
From
Stockmarket.com
Could Cassava Sciences Be a Millionaire-Maker Stock?
February 11, 2021
This company's experimental Alzheimer's disease drug looks very promising, but there are a few key caveats.
Tags
SAVA
PFE
HLUKF
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.